Switch to: References

Add citations

You must login to add citations.
  1. Should rare diseases get special treatment?Monica Magalhaes - 2022 - Journal of Medical Ethics 48 (2):86-92.
    Orphan drug policy often gives ‘special treatment’ to rare diseases, by giving additional priority or making exceptions to specific drugs, based on the rarity of the conditions they aim to treat. This essay argues that the goal of orphan drug policy should be to make prevalence irrelevant to funding decisions. It aims to demonstrate that it is severity, not prevalence, which drives our judgments that important claims are being overlooked when treatments for severe rare diseases are not funded. It shows (...)
    Direct download (3 more)  
    Export citation  
    Bookmark   3 citations  
  • Hope or despair: a response to ‘Do not despair about severity—yet’.Daniel Hausman - 2020 - Journal of Medical Ethics 46 (8):559-559.
    This is a brief response to ‘Do not despair about severity—yet’ by Barra et al. It argues that they have no serious criticisms of Daniel Hausman’s essay, ‘The Significance of Severity’” and that indeed their work lends further support to his view that there is no justification for prioritising severity. As policy-akers, Barra and his coauthors are more constrained by popular attitudes, which apparently favour prioritising severity.
    Direct download (5 more)  
    Export citation  
    Bookmark   1 citation